-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D6572RgEaby+apM9qLx5Q9cdo3ZE3IfmZqFUs1Y6MpYmCRpooIFQfl1/xzs9XUYp vLAaBUrLQU9fuPe6usbPSw== 0001179110-06-017222.txt : 20060821 0001179110-06-017222.hdr.sgml : 20060821 20060821205441 ACCESSION NUMBER: 0001179110-06-017222 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060811 FILED AS OF DATE: 20060821 DATE AS OF CHANGE: 20060821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Montgomery Alan Bruce CENTRAL INDEX KEY: 0001313936 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 061047500 BUSINESS ADDRESS: BUSINESS PHONE: 206-728-5090 MAIL ADDRESS: STREET 1: 2025 1ST AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 3 1 edgar.xml FORM 3 - X0202 3 2006-08-11 0 0000882095 GILEAD SCIENCES INC GILD 0001313936 Montgomery Alan Bruce 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 SVP, Respiratory Therapeutics Common Stock 280 D Common Stock 80 I by immediate family member Incentive Stock Option (right to buy) 11.74 2014-01-15 Common Stock 14919 D Incentive Stock Option (right to buy) 20.11 2014-07-20 Common Stock 11189 D Non-qualified Stock Option (right to buy) 20.11 2014-07-20 Common Stock 12800 D Incentive Stock Option (right to buy) 40.22 2015-01-12 Common Stock 391 D Non-qualified Stock Option (right to buy) 40.22 2015-01-12 Common Stock 1174 D Incentive Stock Option (right to buy) 31.84 2015-07-27 Common Stock 2237 D Non-qualified Stock Option (right to buy) 31.84 2015-07-27 Common Stock 6713 D Non-qualified Stock Option (right to buy) 31.84 2016-06-07 Common Stock 4475 D Shares held by family member/s of Dr. Montgomery. Options vested 25% on January 15, 2005, the first anniversary date of the grant. The balance vests 25% annually thereafter and will be fully vested on January 15, 2008. Options vested 25% on July 20, 2005, the first anniversary date of the grant. The balance vests 25% annually thereafter and will be fully vested on July 20, 2008. Options vest 25% on the January 12, 2006, the first anniversary date of the grant. The balance vests 25% annually thereafter and will be fully vested on January 12, 2009. Options vested 25% on July 27, 2006, the first anniversary date of the grant. The balance vests 25% annually thereafter and will be fully vested on July 27, 2009. Options will vest 100% on April 26, 2007, 320 days from date of grant. John Milligan, by Power of Attorney for A. Bruce Montgomery, M.D. 2006-08-21 EX-24.TXT 2 poa-b_montgomery.txt POWER OF ATTORNEY AUTHORIZATION LETTER Augsut 9, 2006 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Attn: Filing Desk To Whom It May Concern: By means of this letter I authorize Mark L. Perry, John F Milligan, Gregg H. Alton, ESQ.and Matthew K. Au, or any of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock of derivative securities of Gilead Sciences, Inc. (the "Company"). Any of these individuals is accordingly authorized to sign any Form 3, Form 4, Form 5 or amendment thereto which I am required to file with the same effect as if I had signed them myself. This authorization shall remain in effect until revoked in writing by me. Yours truly, /s/ A. Bruce Montgomery, M.D. POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark L. Perry, John F, Milligan, Gregg H. Alton, Esq., and Matthew K. Au signing individually, the undersigned's true and lawful attorneys-in-fact and agents to: (1) execute for and on behalf of the undersigned, an officer or director of Gilead Sciences, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute and amendment or amendments thereto, and timely file such forms or amendments with United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney- in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, fully to all intents and purpose as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney's-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact shall no longer be employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of August, 2006. /s/ A. Bruce Montgomery, M.D. -----END PRIVACY-ENHANCED MESSAGE-----